Tweet from EricTopol at March 29, 2022 at 07:15AM
A third study of neutralizing antibodies (nAb) for BA.1 and BA.2 compared with the original strain. About 10% less for BA.2 vs BA.1. We haven’t seen significant spread of BA.3 but this looks unfavorable for nAb response
https://t.co/5Xkz7fJpOi https://t.co/Zu0ScclSN8— Eric Topol (@EricTopol)
Mar 29, 2022
from http://twitter.com/EricTopol